Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Improving non-invasive monitoring of metabolite levels using MR spectroscopy techniques

Official title: Evaluation of Novel and Adapted MR Spectroscopy and Metabolic Imaging Techniques for Non-invasive Monitoring of Metabolite Levels in Humans in Physiologic States of Everyday Life

Run by Insel Gruppe AG, University Hospital Bern · NCT05165537 · Data updated 2026-11-12

This study is testing new MRI techniques to see if they can better measure certain substances in healthy people’s bodies over time or after exercise.

More Magnetic Resonance Spectroscopy trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorInsel Gruppe AG, University Hospital Bern
Academic / other
Locations1 site (Bern, PhD)
StatusRecruiting
StartedMarch 1, 2022
Main results expectedDecember 2028
Study endsDecember 2028
Registry record updatedApril 29, 2026
Trial IDNCT05165537 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy adults who can lie still in an MRI scanner for at least one hour.

Probably not a fit

Patients with neuronal or metabolic diseases, those under 18 years of age, or individuals with certain implants or large tattoos may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to enhance magnetic resonance spectroscopy (MRS) methods to improve the sensitivity, accuracy, and stability of metabolite measurements in healthy subjects. The study will develop and optimize new MRS techniques to visualize previously undetectable metabolites and assess changes over time or after exercise. The methodology will be validated through in vitro tests followed by trials in healthy participants using certified MRI scanners. The ultimate goal is to make these advanced MRS techniques suitable for routine clinical applications.

Why it matters

Potential benefit: If successful, this study could lead to more accurate and reliable non-invasive assessments of metabolic conditions in patients.

How similar studies have gone: Other studies have shown promise in enhancing MRS techniques, but this specific approach is novel and aims to extend current capabilities.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* signed informed consent
* healthy (no neuronal or metabolic diseases as stated by the study participant)
* able to lie still in the MR scanner for at least one hour

Exclusion Criteria:

* \<18 yrs of age
* pregnancy or current state of lactation
* active implants
* passive ferromagnetic implants
* passive non-ferromagnetic metallic implants \> 4 cm inside a region covered by the active radio-frequency (RF) coils
* large tattoos inside a region covered by the active RF coils
* known or suspected non-compliance,
* under-weight (\<35 kg body weight)

Where it's running

  • Translational Imaging Center
    Bern, PhD, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Roland Kreis, PhD — Inselspital Bern & University Bern
  • Study coordinator: Roland Kreis, PhD
  • Email: roland.kreis@insel.ch
  • Phone: +41316328174

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.